Dimensional Fund Advisors
AMLX icon

Dimensional Fund Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Dimensional Fund Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Sell
902,463
-729
-0.1% -$11.3K ﹤0.01% 2127
2026
Q1 		$12.5M Buy
903,192
+131,944
+17% +$1.86M ﹤0.01% 2171
2025
Q4 		$9.32M Buy
771,248
+261,468
+51% +$3.55M ﹤0.01% 2305
2025
Q3 		$6.94M Buy
509,780
+136,041
+36% +$1.28M ﹤0.01% 2433
2025
Q2 		$2.4M Buy
373,739
+250,163
+202% +$1.22M ﹤0.01% 2719
2025
Q1 		$438K Buy
123,576
+69,462
+128% +$247K ﹤0.01% 3021
2024
Q4 		$205K Buy
+54,114
New +$255K ﹤0.01% 3163

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Dimensional Fund Advisors's AMLX Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Amylyx Pharmaceuticals (AMLX) stake by 0.08% in Q2 2026, selling an estimated $11.3K and leaving 902,463 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Dimensional Fund Advisors first reported a position in AMLX in Q4 2024 and has held it in 7 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Dimensional Fund Advisors held 902,463 shares of Amylyx Pharmaceuticals worth $16.2M as of Q2 2026.
  • Dimensional Fund Advisors sold 729 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $11.3K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2127 holding.
  • Dimensional Fund Advisors first reported a position in Amylyx Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.